---
schema_version: "secwatch.filing_event.v1"
accession: "0001999371-24-000734"
form_type: "8-K"
ticker: null
cik: "0000887247"
company_name: "DMK PHARMACEUTICALS Corp"
filed_at: "2024-01-23T23:59:59+00:00"
generated_at: "2026-06-06T20:23:53.125235+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# DMK Pharmaceuticals amends bylaws to revise stockholder meeting quorum requirements

## Summary
- Effective January 22, 2024, amended bylaws require holders of at least one-third voting power and one-third of common stock shares for quorum.
- Change applies to all stockholder meetings; previous quorum threshold was different.
- Bylaws amendment filed as Exhibit 3.1 to the 8-K.

## SEC filing metadata
- accession: 0001999371-24-000734
- form_type: 8-K
- cik: 0000887247
- company_name: DMK PHARMACEUTICALS Corp
- filed_at: 2024-01-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/887247/000199937124000734/0001999371-24-000734-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/887247/000199937124000734/dmk_8k-012224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001999371-24-000734
- JSON: https://secwatch.observer/filing/0001999371-24-000734.json
- Plain text: https://secwatch.observer/filing/0001999371-24-000734.txt

## Key facts
- Governance Changes
  DMK PHARMACEUTICALS Corp: Amended and restated bylaws to change stockholder meeting quorum requirement to presence of holders of at least one-third of voting power and one-third of common stock shares (effective 2024-01-22).
  - Change: bylaw amendment
  - Effective: 2024-01-22
  source text: Effective January 22, 2024, DMK Pharmaceuticals Corporation (the “Company”) amended and restated its Amended and Restated Bylaws (the “Amended and Restated Bylaws”), to provide that, at all meetings of stockholders, the presence, in person, by remote communication, if applicable, or by proxy, of both (i) the holders of at least one-third of the voting power of the capital stock issued and outstanding and entitled to vote on one or more matters to be voted on at the meeting, and (ii) the holders of at least one-third of all issued and outstanding shares of Common Stock entitled to vote, shall constitute a quorum at all meetings of the stockholders for the transaction of business.
  evidence_url: https://www.sec.gov/Archives/edgar/data/887247/000199937124000734/0001999371-24-000734-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.